Earnings Call · Q4 FY2023·2024-03-27

Q4 23EPS -7.02%·Rev n/aQ3 23EPS -86.07%·Rev n/aQ2 23EPS -9.77%·Rev n/aQ1 23EPS +12.41%·Rev n/a⚠ consensus missing

Cellectar Biosciences, Inc. CLRB

Jim Caruso — Chief Executive Officer

Andrei Shustov — Senior Vice President, Medical

Jarrod Longcor — Chief Operating Officer

Shane Lea — Chief Commercial Officer

Chad Kolean — Chief Financial Officer

−5.6%1d on move date−6.4% vs SPY3d+1.8%5d+3.4%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CLRB calls or request research access.

More CLRB calls Browse calls Request research access